Anti-MARK 1+2+3+4 (phospho T215)抗体(ab111437)

概述

  • 产品名称Anti-MARK 1+2+3+4 (phospho T215)抗体
    参阅全部 MARK 1+2+3+4 一抗
  • 描述
    兔多克隆抗体to MARK 1+2+3+4 (phospho T215)
  • 特异性ab111437 detects endogenous levels of MARK 1+2+3+4 only when phosphorylated at threonine 215 (Human: Thr215/208/235/215; Mouse: Thr215/208/212/215; Rat: Thr215/208/212/-).
  • 经测试应用适用于: IHC-Pmore details
  • 种属反应性
    与反应: Human
    预测可用于: Mouse, Rat
  • 免疫原

    Synthetic phosphopeptide derived from Human MARK 1+2+3+4 around the phosphorylation site of threonine 215 (L-D-TP-F-C).

  • 阳性对照
    • Human breast carcinoma tissue

性能

应用

Our Abpromise guarantee covers the use of ab111437 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
IHC-P 1/50 - 1/100. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

靶标

Anti-MARK 1+2+3+4 (phospho T215) antibody 图像

  • ab111437, at 1/50 dilution, staining MARK 1+2+3+4 in paraffin-embedded Human breast carcinoma tissue by Immunohistochemistry, in the presence (right panel) or absence (left panel) of immunising peptide.

Anti-MARK 1+2+3+4 (phospho T215) antibody (ab111437)参考文献

ab111437 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab111437.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"